tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Valneva Se’s Earnings Call: Mixed Results and Future Prospects
PremiumCompany AnnouncementsValneva Se’s Earnings Call: Mixed Results and Future Prospects
30d ago
Valneva Reports Increased Revenues and Strategic Advances in Vaccine Development
Premium
Company Announcements
Valneva Reports Increased Revenues and Strategic Advances in Vaccine Development
1M ago
Valneva’s Promising Future: Buy Rating Backed by Strong Prospects for Lyme Disease Vaccine and Robust Financial Health
Premium
Ratings
Valneva’s Promising Future: Buy Rating Backed by Strong Prospects for Lyme Disease Vaccine and Robust Financial Health
1M ago
Valneva price target lowered to $13 from $14 at Guggenheim
PremiumThe FlyValneva price target lowered to $13 from $14 at Guggenheim
3M ago
Valneva Reports Positive Phase 2 Results for Lyme Disease Vaccine
Premium
Company Announcements
Valneva Reports Positive Phase 2 Results for Lyme Disease Vaccine
4M ago
Valneva’s Stock: A Buy Rating Amid Overreaction and Promising Vaccine Prospects
Premium
Ratings
Valneva’s Stock: A Buy Rating Amid Overreaction and Promising Vaccine Prospects
4M ago
Valneva SE (ADR) trading halted, news pending
PremiumThe FlyValneva SE (ADR) trading halted, news pending
4M ago
Valneva’s Promising Future: Buy Rating Backed by VLA15 Vaccine and Robust Portfolio
Premium
Ratings
Valneva’s Promising Future: Buy Rating Backed by VLA15 Vaccine and Robust Portfolio
4M ago
Valneva assumed with a Buy at H.C. Wainwright
Premium
The Fly
Valneva assumed with a Buy at H.C. Wainwright
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100